{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:13:15Z","timestamp":1777709595130,"version":"3.51.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,2]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Hepatocellular carcinoma (HCC) is the sixth most common type of cancer globally. Since 2020, combination treatment with atezolizumab and bevacizumab were approved in patients with unresectable HCC in Japan, and atezolizumab plus bevacizumab is the first-line treatment for unresectable HCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 73-year-old Japanese man diagnosed with a large HCC was treated with atezolizumab plus bevacizumab. After 2 cycles, he had fever and fatigue and was admitted to the hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Abdominal contrast-enhanced computed tomography revealed tumor necrosis in HCC with gas formation in the necrotic area. Laboratory examination revealed a white blood cell (WBC) count of 16,340\/\u03bcL and C-reactive protein (CRP) level of 33.0\u2009mg\/dL. Based on the above findings, he was diagnosed with a liver abscess.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Percutaneous transhepatic liver abscess drainage and broad-spectrum antibiotics treatment were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Despite liver abscess drainage, persistent fever and no improvement in the WBC count or CRP level was observed. The patient\u2019s respiratory condition and renal function gradually worsened; The patient\u2019s general condition did not improve despite the ventilator support and continuous hemodiafiltration, and he died on day 37.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We report the first case of liver abscess after atezolizumab plus bevacizumab treatment for unresectable HCC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030486","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:25:43Z","timestamp":1662135943000},"page":"e30486","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Liver abscess in advanced hepatocellular carcinoma after atezolizumab plus bevacizumab treatment: A case report"],"prefix":"10.1097","volume":"101","author":[{"given":"Keisuke","family":"Uchida","sequence":"first","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ozono","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hatada","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Komaki","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Iwakiri","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Hasuike","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nagata","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Division of Pathology, University of Miyazaki Hospital, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-366X","authenticated-orcid":false,"given":"Hiroshi","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758835920927602","article-title":"Is the era of sorafenib over? A review of the literature","volume":"12","author":"Fan","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/flgastro-2013-100371","article-title":"Pyogenic liver abscess","volume":"5","author":"Webb","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1186\/s12879-021-06649-9","article-title":"Epidemiology and risk factors for pyogenic liver abscess in the Calgary Health Zone revisited: a population-based study","volume":"21","author":"Losie","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiol.2262012198","article-title":"Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study","volume":"226","author":"Livraghi","year":"2003","journal-title":"Radiology"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.meg.0000108361.41221.8c","article-title":"Liver abscess complicating transcatheter arterial embolization: a rare but serious complication. A retrospective study after 3878 procedures","volume":"16","author":"Ong","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4166\/kjg.2014.63.1.47","article-title":"Liver abscess in advanced hepatocellular carcinoma after sorafenib treatment","volume":"63","author":"Shin","year":"2014","journal-title":"Korean J Gastroenterol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1200\/JCO.2007.13.9220","article-title":"Sepsis from liver abscesses in metastatic colorectal carcinoma after chemoimmunotherapy","volume":"26","author":"Lieuw-a-Fa","year":"2008","journal-title":"J Clin Oncol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.2147\/CMAR.S328812","article-title":"Increased liquefactive necrosis formation after transarterial chemoembolization combined with molecular targeted agents plus immune checkpoint inhibitors for hepatocellular carcinoma","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14701\/ahbps.2018.22.1.11","article-title":"Gas-forming pyogenic liver abscess: a world review","volume":"22","author":"Thng","year":"2018","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/sur.2020.245","article-title":"Clinical features and prognosis of gas-forming and non-gas-forming pyogenic liver abscess: a comparative study.","volume":"22","author":"Zhang","year":"2021","journal-title":"Surg Infect"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1089\/sur.2019.278","article-title":"Outcomes of gas-forming pyogenic liver abscess are comparable to non-gas-forming pyogenic liver abscess in the era of multi-modal care: a propensity score matched study.","volume":"21","author":"Chan","year":"2020","journal-title":"Surg Infect"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"e00736","DOI":"10.1016\/j.idcr.2020.e00736","article-title":"Raoultella ornithinolytica and Klebsiella oxytoca pyogenic liver abscess presenting as chronic cough","volume":"20","author":"Surani","year":"2020","journal-title":"IDCases"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1099\/00207713-51-3-925","article-title":"Phylogenetic analyses of Klebsiella species delineate Klebsiella and Raoultella gen. nov., with description of Raoultella ornithinolytica comb. nov., Raoultella terrigena comb. nov. and Raoultella planticola comb. nov","volume":"51","author":"Drancourt","year":"2001","journal-title":"Int J Syst Evol Microbiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2016.02.014","article-title":"Emerging role of Raoultella ornithinolytica in human infections: a series of cases and review of the literature","volume":"45","author":"Seng","year":"2016","journal-title":"Int J Infect Dis"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0256-4947.75794","article-title":"A rare human infection of Raoultella ornithinolytica in a diabetic foot lesion","volume":"31","author":"Solak","year":"2011","journal-title":"Ann Saudi Med"},{"key":"R20-20250504","first-page":"rjy097","article-title":"Community-acquired infection to Raoultella ornithinolytica presenting as appendicitis and shock in a healthy individual","volume":"15","author":"Hajjar","year":"2018","journal-title":"J Surg Case Rep"},{"key":"R21-20250504","first-page":"1911","article-title":"Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics","volume":"88","author":"Yang","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2957\/kanzo.62.80","article-title":"A useful case of tumor resection and monitoring the blood concentration at lenvatinib therapy for multiple hepatocellular carcinoma","volume":"62","author":"Osaki","year":"2021","journal-title":"Kanzo"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:36:36Z","timestamp":1746333396000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":22,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030486","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]}}}